Entire Transcript in Adobe Acrobat Format - National Reference ...

21
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
the prospective so it does not make any sense to me not to
collapse them.
DR. EMANUEL: Well, I think the way to
understand that is to work through each of the boxes as the
subcommittee did and the rationale for them. Let me
emphasize what I think are the -- and I would hope that my
fellow commissioners would again -- the three path
breaking, I think, distinctions we have made. One is
between the previously collected samples and the samples
collected after the report's recommendations.
The second is that the evaluation, the ethical
evaluation, should be based on the use of the tissue, not
on the manner of collection or storage of the tissue,
because what we are interested in, and the reasons we have
worries is the harms that result and that depends upon
being able to identify a specific result with a specific
person, and that recognition that some research conducted
on individually anonymous -- in an individually anonymous
manner may nevertheless have sufficient sociodemographic
information to adversely affect communities.
MR. CAPRON: Could you pause now because --
DR. EMANUEL: Well, let --
MR. CAPRON: -- because you think you have
responded --